The effect of cardiac resynchronization on morbidity and mortality in heart failure

JGF Cleland, JC Daubert, E Erdmann, Nick Freemantle, D Gras, L Kappenberger, L Tavazzi

    Research output: Contribution to journalArticle

    4864 Citations (Scopus)

    Abstract

    BACKGROUND: Cardiac resynchronization reduces symptoms and improves left ventricular function in many patients with heart failure due to left ventricular systolic dysfunction and cardiac dyssynchrony. We evaluated its effects on morbidity and mortality. METHODS: Patients with New York Heart Association class III or IV heart failure due to left ventricular systolic dysfunction and cardiac dyssynchrony who were receiving standard pharmacologic therapy were randomly assigned to receive medical therapy alone or with cardiac resynchronization. The primary end point was the time to death from any cause or an unplanned hospitalization for a major cardiovascular event. The principal secondary end point was death from any cause. RESULTS: A total of 813 patients were enrolled and followed for a mean of 29.4 months. The primary end point was reached by 159 patients in the cardiac-resynchronization group, as compared with 224 patients in the medical-therapy group (39 percent vs. 55 percent; hazard ratio, 0.63; 95 percent confidence interval, 0.51 to 0.77; P
    Original languageEnglish
    Pages (from-to)1539-1549
    Number of pages11
    JournalNew England Journal of Medicine
    Volume352
    DOIs
    Publication statusPublished - 14 Apr 2005

    Fingerprint

    Dive into the research topics of 'The effect of cardiac resynchronization on morbidity and mortality in heart failure'. Together they form a unique fingerprint.

    Cite this